VERA Vera Therapeutics Inc

Price (delayed)

$33.77

Market cap

$2.42B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.54

Enterprise value

$2.38B

?
Relative Growth: Rel. Growth: 0
Relative Strength: Rel. Strength: 36
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 2
Highlights
The net income has plunged by 110% YoY and by 23% from the previous quarter
VERA's EPS has dropped by 85% year-on-year and by 19% since the previous quarter

Key stats

What are the main financial stats of VERA

VERA stock price

How has the Vera Therapeutics stock price performed over time
Intraday
7.99%
1 week
-5.83%
1 month
-4.9%
1 year
5.55%
YTD
-33.31%
QTD
-16.06%

Financial performance

How have Vera Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$383.41M
Net income
-$368.95M
Gross margin
N/A
Net margin
N/A
The net income has plunged by 110% YoY and by 23% from the previous quarter
VERA's operating income has dropped by 98% year-on-year and by 22% since the previous quarter

Price vs fundamentals

How does VERA's price correlate with its fundamentals

Growth

What is Vera Therapeutics's growth rate over time

Valuation

What is Vera Therapeutics stock price valuation
P/E
N/A
P/B
4.82
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
VERA's EPS has dropped by 85% year-on-year and by 19% since the previous quarter
VERA's equity is down by 17% since the previous quarter and by 7% year-on-year
VERA's P/B is 12% less than its 5-year quarterly average of 5.1 and 4.9% less than its last 4 quarters average of 4.7

Efficiency

How efficient is Vera Therapeutics business performance
The ROIC has plunged by 110% YoY and by 27% from the previous quarter
VERA's return on equity has dropped by 84% year-on-year and by 25% since the previous quarter
The ROA has dropped by 74% year-on-year and by 23% since the previous quarter

Dividends

What is VERA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VERA.

Financial health

How did Vera Therapeutics financials performed over time
The total liabilities has surged by 62% year-on-year but it has declined by 6% since the previous quarter
The quick ratio has plunged by 51% YoY
VERA's debt is 85% smaller than its equity
Vera Therapeutics's debt to equity has surged by 50% YoY and by 25% QoQ
VERA's debt is up by 38% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.